High-end newsletter focused on small-cap biotech stocks, using what they call their CASH system to select recommended stocks (Catalysts, large Addressable market, good Science, and a potential Hype story). Wood also edits the “entry level” healthcare investment advisory Healthy Returns.
Articles
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
Is C-V2X on the US Stock exchange? My online brokerage account can't find it....
Osteoarthritis is a major debilitator of older people. The only solution today is to go under the knife to have joints s...